浙江临床医学
浙江臨床醫學
절강림상의학
ZHEJIANG CLINICAL MEDICAL JOURNAL
2013年
10期
1464-1465,1466
,共3页
苏牟潇%陈忠伦%姚力瑛
囌牟瀟%陳忠倫%姚力瑛
소모소%진충륜%요력영
依达拉奉%急性一氧化碳中毒后迟发性脑病%神经元特异性烯醇化酶%超氧化物歧化酶
依達拉奉%急性一氧化碳中毒後遲髮性腦病%神經元特異性烯醇化酶%超氧化物歧化酶
의체랍봉%급성일양화탄중독후지발성뇌병%신경원특이성희순화매%초양화물기화매
Edaravone%Delayed encephalopathy after acute carbon monoxide poisoning%Neuron-specific enolase%Super oxide dismutase
目的:探讨依达拉奉对急性一氧化碳中毒迟发性脑病(DEACMP)患者血清神经元特异性烯醇化酶(NSE)、超氧化物歧化酶(SOD)的影响。方法将DEACMP患者46例随机分为观察组和对照组,各23例,对照组给予高压氧及胞磷胆碱钠注射液等常规治疗,观察组在常规治疗基础上给予依达拉奉注射液30mg静脉滴注,2次/d,治疗14d。在治疗前及治疗后第3、7、14天,利用酶联免疫吸附法检测患者血清NSE浓度,用黄嘌呤氧化酶法检测患者血清SOD浓度及在治疗前、治疗后第14天做简易智能精神量表(MMSE)评分,进行比较。结果观察组有效率90.3%,对照组65.3%;观察组患者血清NSE浓度明显下降,低于对照组(P<0.05),SOD浓度升高,高于对照组(P<0.05);观察组MMSE评分改善优于对照组(P<0.05),结论依达拉奉注射液可以有效降低DEACMP患者血清NSE浓度,提高SOD活性,对DEACMP有较好疗效。
目的:探討依達拉奉對急性一氧化碳中毒遲髮性腦病(DEACMP)患者血清神經元特異性烯醇化酶(NSE)、超氧化物歧化酶(SOD)的影響。方法將DEACMP患者46例隨機分為觀察組和對照組,各23例,對照組給予高壓氧及胞燐膽堿鈉註射液等常規治療,觀察組在常規治療基礎上給予依達拉奉註射液30mg靜脈滴註,2次/d,治療14d。在治療前及治療後第3、7、14天,利用酶聯免疫吸附法檢測患者血清NSE濃度,用黃嘌呤氧化酶法檢測患者血清SOD濃度及在治療前、治療後第14天做簡易智能精神量錶(MMSE)評分,進行比較。結果觀察組有效率90.3%,對照組65.3%;觀察組患者血清NSE濃度明顯下降,低于對照組(P<0.05),SOD濃度升高,高于對照組(P<0.05);觀察組MMSE評分改善優于對照組(P<0.05),結論依達拉奉註射液可以有效降低DEACMP患者血清NSE濃度,提高SOD活性,對DEACMP有較好療效。
목적:탐토의체랍봉대급성일양화탄중독지발성뇌병(DEACMP)환자혈청신경원특이성희순화매(NSE)、초양화물기화매(SOD)적영향。방법장DEACMP환자46례수궤분위관찰조화대조조,각23례,대조조급여고압양급포린담감납주사액등상규치료,관찰조재상규치료기출상급여의체랍봉주사액30mg정맥적주,2차/d,치료14d。재치료전급치료후제3、7、14천,이용매련면역흡부법검측환자혈청NSE농도,용황표령양화매법검측환자혈청SOD농도급재치료전、치료후제14천주간역지능정신량표(MMSE)평분,진행비교。결과관찰조유효솔90.3%,대조조65.3%;관찰조환자혈청NSE농도명현하강,저우대조조(P<0.05),SOD농도승고,고우대조조(P<0.05);관찰조MMSE평분개선우우대조조(P<0.05),결론의체랍봉주사액가이유효강저DEACMP환자혈청NSE농도,제고SOD활성,대DEACMP유교호료효。
Objective TO Investigate the effect of Edaravone on content of serum NSE、SOD in delayed encephalopathy after acute carbon monoxide poisoning. Methods 46 patients with DEACMP were divided into two groups randomly.Both the groups were treated with normal method and the treatment group was given edaravone 30mg,twice a day, total of 14d.The serum levers of NSE、SOD were measured by ELISA、Xanthine oxidase from buttermilk before treatment and at the time of 3,7,14d.MMSE were measured before treatment and 14d after treatment. Results The serum levers of NSE of Edaravone group was lower than of contral group(P<0.05). The serum levers of SOD and MMSE scores of Edaravone group were higher than of contral group(P<0.05). Conclusion Edaravone may protect against DEACMP.